Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000045

CEO bought 89,500 shares at an average $0.01 ($918)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

16 lines
Date Transaction Shares Price Value Owned after D/I
2019-08-08 Purchase : show line 1 in the form +2,000 $0.01 $20 24,922,797 D
2019-08-08 Purchase : show line 2 in the form +3,000 $0.01 $30 24,925,797 D
2019-08-08 Purchase : show line 3 in the form +5,000 $0.01 $51 24,930,797 D
2019-08-08 Purchase : show line 4 in the form +5,000 $0.01 $51 24,935,797 D
2019-08-08 Purchase : show line 5 in the form +10,000 $0.01 $100 24,945,797 D
2019-08-08 Purchase : show line 6 in the form +50 $0.01 $1 24,945,847 D
2019-08-08 Purchase : show line 7 in the form +19,950 $0.01 $201 24,965,797 D
2019-08-08 Purchase : show line 8 in the form +10,000 $0.01 $101 24,975,797 D
Open-market purchases · 89,500 sh · avg $0.01 · $918
Loading xslF345X03/primary_doc.xml…